Andrew N Bubak Selected Research

nimbin

1/2022

Azadirachta indica A. Juss bark extract and its Nimbin isomers restrict β-coronaviral infection and replication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew N Bubak Research Topics

Disease

10	Infections 01/2022 - 01/2018
8	Virus Diseases (Viral Diseases) 01/2022 - 01/2018
5	Herpes Zoster 01/2022 - 01/2018
4	Stroke (Strokes) 01/2022 - 01/2018
3	Diabetes Mellitus 01/2022 - 01/2020
3	Inflammation (Inflammations) 01/2022 - 01/2019
2	Chickenpox 01/2022 - 12/2020
2	Vascular Diseases (Vascular Disease) 01/2022 - 01/2018
2	Central Nervous System Infections (Central Nervous System Infection) 01/2021 - 01/2020
2	Exanthema (Rash) 01/2020 - 01/2018
2	Dementia (Dementias) 01/2020 - 01/2020
2	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 01/2020
2	Disease Progression 01/2020 - 01/2020
2	Spinal Cord Diseases 11/2018 - 01/2018
1	Amyloidosis 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Fatigue 01/2022
1	Nausea 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Coronavirus Infections 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Tauopathies 01/2022
1	Vascular Remodeling 01/2022
1	Giant Cell Arteritis (Horton Disease) 11/2021
1	Systemic Vasculitis 11/2021
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 03/2021
1	Vasculitis (Vasculitides) 01/2021
1	Arteritis 01/2021
1	Rupture 12/2020
1	Atherosclerotic Plaque (Atheroma) 12/2020
1	Thrombophilia 12/2020
1	Varicella Zoster Virus Infection 01/2020
1	Keratitis 01/2019
1	Brain Diseases (Brain Disorder) 11/2018
1	Myocardial Infarction 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2015

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
4	AntigensIBA 01/2022 - 01/2019
4	Islet Amyloid PolypeptideIBA 01/2022 - 01/2020
4	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2020
4	AntibodiesIBA 01/2022 - 11/2018
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
2	Transient Receptor Potential ChannelsIBA 03/2021 - 12/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2020
1	nimbinIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	CatecholaminesIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	MineralocorticoidsIBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022
1	TriterpenesIBA 01/2022
1	TubulinIBA 01/2022
1	Viral ProteinsIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	Caspase 9IBA 01/2022
1	Presenilin-1IBA 01/2022
1	Formaldehyde (Formol)FDA Link 11/2021
1	ParaffinIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 11/2021
1	NF-kappa B (NF-kB)IBA 11/2021
1	Complementary DNA (cDNA)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Substance PIBA 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2020
1	CytokinesIBA 11/2018
1	Glial Fibrillary Acidic ProteinIBA 11/2018
1	NucleosidesIBA 01/2018
1	LigandsIBA 01/2018
1	rolapitantIBA 01/2018
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2018
1	Aprepitant (Emend)FDA Link 01/2018
1	suberoylbisphosphonic acid (SuBP)IBA 01/2018
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2018
1	Glycemic Control 01/2020